137 related articles for article (PubMed ID: 8853809)
41. Perfluorodecalin emulsion tested for biocompatibility in macrophages by means of a magnetometric method.
Koester M; Lutz J; Augustin AJ; Meinert H
Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1231-6. PubMed ID: 7849927
[TBL] [Abstract][Full Text] [Related]
42. Perfluorochemical emulsions decrease Kupffer cell phagocytosis.
Bottalico LA; Betensky HT; Min YB; Weinstock SB
Hepatology; 1991 Jul; 14(1):169-74. PubMed ID: 2066065
[TBL] [Abstract][Full Text] [Related]
43. Survival of guinea pig cardiac xenografts in C6-deficient PVG rats treated with monoclonal antibody to CD18.
Brauer RB; Baldwin WM; Pruitt SK; Sanfilippo F
Transplant Proc; 1994 Jun; 26(3):1251. PubMed ID: 7913260
[No Abstract] [Full Text] [Related]
44. Development of a perfluorochemical emulsion as a blood gas carrier.
Mitsuno T; Ohyanagi H; Yokoyama K
Artif Organs; 1984 Feb; 8(1):25-33. PubMed ID: 6422912
[TBL] [Abstract][Full Text] [Related]
45. Intermittent use of a perfluorochemical emulsion (Fluosol-DA 20%) and carbogen breathing with fractionated irradiation.
Moulder JE; Fish BL
Int J Radiat Oncol Biol Phys; 1988 Nov; 15(5):1193-6. PubMed ID: 3141322
[TBL] [Abstract][Full Text] [Related]
46. Red blood cell substitutes and artificial blood.
Bowman RJ
Hum Pathol; 1983 Mar; 14(3):218-20. PubMed ID: 6832769
[TBL] [Abstract][Full Text] [Related]
47. Phylogenetic disparity does not always equate with hyperacute rejection in xenotransplantation.
Braidley PC; Dunning JJ; Wallwork J; White DJ
Transplant Proc; 1994 Jun; 26(3):1230-1. PubMed ID: 8029897
[No Abstract] [Full Text] [Related]
48. Development and clinical application of perfluorochemical artificial blood.
Ohyanagi H; Saitoh Y
Int J Artif Organs; 1986 Sep; 9(5):363-8. PubMed ID: 3781670
[TBL] [Abstract][Full Text] [Related]
49. Complement- and xenoantibody-independent discordant xenograft rejection in a guinea pig to rat model.
Ji P; Xia GL; Waer M
Transplant Proc; 2000 Aug; 32(5):935. PubMed ID: 10936281
[No Abstract] [Full Text] [Related]
50. Clinical studies of a perfluorochemical whole blood substitute (Fluosol-DA) Summary of 186 cases.
Mitsuno T; Ohyanagi H; Naito R
Ann Surg; 1982 Jan; 195(1):60-9. PubMed ID: 7034658
[TBL] [Abstract][Full Text] [Related]
51. Lymphoid tissue responses to concentrated perfluorochemical emulsions in rats.
Bentley PK; Johnson OL; Washington C; Lowe KC
Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):1033-6. PubMed ID: 1391423
[TBL] [Abstract][Full Text] [Related]
52. (Pyridoxylated hemoglobin)-(polyoxyethylene) conjugate solution as blood substitute for normothermic whole body rinse-out.
Agishi T; Funakoshi Y; Honda H; Yamagata K; Kobayashi M; Takahashi M
Biomater Artif Cells Artif Organs; 1988; 16(1-3):261-70. PubMed ID: 3179468
[TBL] [Abstract][Full Text] [Related]
53. Dose-dependent reduction of myocardial infarct size with the perfluorochemical Fluosol-DA.
Rice HE; Virmani R; Hart CL; Kolodgie FD; Farb A
Am Heart J; 1990 Nov; 120(5):1039-46. PubMed ID: 2239656
[TBL] [Abstract][Full Text] [Related]
54. [Fine-structural analysis of hyper-acute rejection in cardiac xenotransplantation].
Miyazaki K
Hokkaido Igaku Zasshi; 2000 Sep; 75(5):347-56. PubMed ID: 11070795
[TBL] [Abstract][Full Text] [Related]
55. T cell independence of macrophage and natural killer cell infiltration, cytokine production, and endothelial activation during delayed xenograft rejection.
Candinas D; Belliveau S; Koyamada N; Miyatake T; Hechenleitner P; Mark W; Bach FH; Hancock WW
Transplantation; 1996 Dec; 62(12):1920-7. PubMed ID: 8990388
[TBL] [Abstract][Full Text] [Related]
56. Elucidation of rejection mechanisms using the splenocyte injection model in concordant xenotransplantation.
Yasutomi M; Hayashi S; Ohtsuka S; Namii Y; Ito M; Uchida K; Yokoyama I; Takagi H
Transplant Proc; 1995 Apr; 27(2):1583-4. PubMed ID: 7725417
[No Abstract] [Full Text] [Related]
57. The study of mitoxantrone as a potential immunosuppressor in transgenic pig renal xenotransplantation in baboons: comparison with cyclophosphamide.
Ashton-Chess J; Meurette G; Karam G; Petzold T; Minault D; Naulet J; Tesson L; Plat M; Anegon I; Soulillou JP; Blancho G
Xenotransplantation; 2004 Mar; 11(2):112-22. PubMed ID: 14962273
[TBL] [Abstract][Full Text] [Related]
58. Effects of synthetic blood and crystalloid cardioplegic solutions on coronary endothelium: an experimental scanning electron microscope study.
Harjula A; Mattila S; Myllärniemi H; Mattila I; Mattila P; Salmenperä M; Merikallio E
J Surg Res; 1985 Nov; 39(5):405-12. PubMed ID: 4058003
[TBL] [Abstract][Full Text] [Related]
59. Heart and liver xenotransplantation under low-dose tacrolimus: graft survival after withdrawal of immunosuppression.
Molleví DG; Ribas Y; Ginesta MM; Serrano T; Mestre M; Vidal A; Figueras J; Jaurrieta E
Transplantation; 2001 Jan; 71(2):217-23. PubMed ID: 11213062
[TBL] [Abstract][Full Text] [Related]
60. Effect of graft preservation and IgM depletion on guinea pig to rat cardiac xenograft survival.
Hori S; Havaux X; Rubay R; Latinne D; Bazin H; Gianello P
Transplantation; 1997 Jun; 63(11):1554-61. PubMed ID: 9197345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
